NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond

José Martínez-González1,2,3, Laia Cañes1,2,3, Judith Alonso1,2,3

  • 1Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), 08036 Barcelona, Spain.

Insights

Nuclear receptors NR4A3 (NOR-1) are key regulators of cardiovascular remodeling in diseases like atherosclerosis. This review highlights their role in immune cell activation and tissue repair processes in cardiovascular diseases.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Immunology

Background:

  • Vascular and inflammatory immune cell activation drives tissue remodeling in cardiovascular diseases (CVDs).
  • Cardiovascular remodeling involves complex cellular processes like proliferation, apoptosis, inflammation, and extracellular matrix dynamics.
  • Nuclear receptors of the subfamily 4 group A (NR4A) are emerging as critical regulators in various cellular functions and pathologies.

Purpose of the Study:

  • To review the significant findings concerning NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1).
  • To elucidate the role of NR4A3 in cardiovascular remodeling within the context of CVDs.
  • To connect NR4A3's function to immune cell responses and tissue repair mechanisms.

Main Methods:

  • Literature review of studies investigating NR4A3 in cardiovascular diseases.
  • Analysis of research on NR4A3's involvement in immune cell activation and vascular inflammation.
  • Synthesis of data on NR4A3's impact on cellular processes relevant to cardiovascular remodeling.

Main Results:

  • NR4A3 (NOR-1) is implicated as a master gene in regulating key cellular processes during cardiovascular remodeling.
  • NR4A3 influences the activation and response of vascular and inflammatory immune cells.
  • Findings link NR4A3 to pathologies such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm.

Conclusions:

  • NR4A3 (NOR-1) plays a pivotal role in the cardiovascular remodeling associated with major CVDs.
  • Understanding NR4A3's mechanisms offers potential therapeutic targets for cardiovascular diseases.
  • NR4A3 is a crucial link between immune responses and tissue remodeling in cardiovascular pathology.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.8K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
2.7K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
9.8K